World Advanced Therapies & Regenerative Medicine Congress
Date: | 17-May-17 to 19-May-17 |
Location: | Business Design Centre, London / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
In May 2017 the newly named World Advanced Therapies & Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic.
The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals.
Key topics include:
• The next generation of ATMPs
• Regulation, reimbursement & commercialisation for advanced therapies around the globe
• CRISPR & gene editing
• Stem cells as a tool for drug discovery
• What’s next for cell and gene therapy, new era of regenerative medicine?
• New paradigms in manufacture: gene therapy & viral vectors
• Clinical development of immunotherapy & cell therapy
• New frontiers in repair and replacement of diseased tissues & organs
• Product, process & manufacturing development of ATMPS
The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals.
Key topics include:
• The next generation of ATMPs
• Regulation, reimbursement & commercialisation for advanced therapies around the globe
• CRISPR & gene editing
• Stem cells as a tool for drug discovery
• What’s next for cell and gene therapy, new era of regenerative medicine?
• New paradigms in manufacture: gene therapy & viral vectors
• Clinical development of immunotherapy & cell therapy
• New frontiers in repair and replacement of diseased tissues & organs
• Product, process & manufacturing development of ATMPS
Exhibitors
William (Bill) Burns, Governor and Trustee, Wellcome Trust, Vice Chairman, Vestergaard; Trustee, Institute of Cancer Research, London; Vice Chairman, Mesoblast, • Joanne Kurtzberg, Director, Carolinas Cord Blood Bank, Duke University, • Susan Solomon, CEO and Co-Founder, New York Stem Cell Foundation, • Sonia Quaratino, Global Clinical Program Leader, Novartis Institutes For BioMedical Research, • Sven Kili, Vice President & Head, Gene Therapy Development, GSK
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today